Efficacy and safety of first-line chemotherapy combined with immune checkpoint inhibitors for extensive-stage small cell lung cancer patients: a real-world propensity score matching study

Backgroundextensive-stage small cell lung cancer (ES-SCLC) were the majority of SCLC patients. Recently the combination of chemotherapy with immune checkpoint inhibitors (ICIs) have emerged as the new first-line treatment standard for ES-SCLC. However, the specific patient populations that are most...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Bin Jia, Chenyi Zhou, Fei Zhao, Xiaoru Song, Yuan Ding, Xiyin Wang, Boying Wu, Huina Wang, Quanman Hu, Shuaiyin Chen
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2025-08-01
Σειρά:	Frontiers in Immunology
Θέματα:	ES-SCLC chemotherapy ICIs PSM COX prognostic
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1562458/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!